HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyeong Ryang Park Selected Research

KRC-108

2/2016Resistance to the c-Met inhibitor KRC-108 induces the epithelial transition of gastric cancer cells.
6/2015Effects of KRC-108 on the Aurora A activity and growth of colorectal cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyeong Ryang Park Research Topics

Disease

4Neoplasms (Cancer)
03/2019 - 06/2015
2Stomach Neoplasms (Stomach Cancer)
03/2019 - 02/2016
2Colorectal Neoplasms (Colorectal Cancer)
04/2017 - 06/2015
1Carcinoma (Carcinomatosis)
02/2016

Drug/Important Bio-Agent (IBA)

2indirubinIBA
03/2019 - 04/2017
2Phosphotransferases (Kinase)IBA
03/2019 - 06/2015
2KRC-108IBA
02/2016 - 06/2015
1Proteins (Proteins, Gene)FDA Link
03/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2019
1Aurora Kinase AIBA
04/2017
1Antineoplastic Agents (Antineoplastics)IBA
02/2016
1Cadherins (E-Cadherin)IBA
02/2016